Julie Vergara Selected Research

Leprosy (Hansen's Disease)

11/2020

A phase 1 antigen dose escalation trial to evaluate safety, tolerability and immunogenicity of the leprosy vaccine candidate LepVax (LEP-F1 + GLA-SE) in healthy adults.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julie Vergara Research Topics

Disease

3	Tuberculosis (Tuberculoses) 01/2023 - 01/2018
3	Visceral Leishmaniasis (Kala Azar) 01/2017 - 04/2015
2	Malaria 01/2017 - 12/2013
2	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 11/2002 - 10/2002
1	Leprosy (Hansen's Disease) 11/2020
1	Pulmonary Tuberculosis 01/2018
1	Latent Infection 01/2017
1	Infections 01/2017
1	Leishmaniasis 04/2015
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2006
1	Sporadic Creutzfeldt-Jakob Disease 01/2006
1	Bovine Spongiform Encephalopathy (Mad Cow Disease) 11/2002
1	Chronic Wasting Disease 11/2002
1	Scrapie 10/2002
1	Neurologic Manifestations (Neurological Manifestations) 10/2002
1	Gliosis 10/2002

Drug/Important Bio-Agent (IBA)

6	AntigensIBA 11/2020 - 12/2013
5	VaccinesIBA 01/2021 - 01/2016
3	Subunit VaccinesIBA 01/2023 - 04/2015
3	PrionsIBA 01/2006 - 10/2002
1	Cysteine Proteases (Cysteine Protease)IBA 01/2017
1	EmulsionsIBA 01/2017
1	glucopyranosyl lipid-AIBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 12/2013
1	Protein Subunit VaccinesIBA 12/2013
1	A-factor (Streptomyces)IBA 01/2006
1	Protein Isoforms (Isoforms)IBA 10/2002